Wendell David Associates’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.89M Sell
10,743
-50
-0.5% -$17.1K 0.41% 55
2026
Q1
$3.8M Sell
10,793
-35
-0.3% -$12.5K 0.41% 54
2025
Q4
$3.54M Sell
10,828
-36
-0.3% -$11.4K 0.36% 54
2025
Q3
$3.07M Hold
10,864
0.3% 63
2025
Q2
$3.03M Sell
10,864
-21
-0.2% -$5.95K 0.31% 64
2025
Q1
$3.39M Sell
10,885
-662
-6% -$195K 0.34% 57
2024
Q4
$3.01M Hold
11,547
0.3% 61
2024
Q3
$3.72M Buy
11,547
+124
+1% +$40.6K 0.36% 54
2024
Q2
$3.57M Sell
11,423
-25
-0.2% -$7.34K 0.36% 53
2024
Q1
$3.25M Buy
11,448
+23
+0.2% +$6.73K 0.33% 59
2023
Q4
$3.29M Buy
11,425
+30
+0.3% +$8.17K 0.35% 59
2023
Q3
$3.06M Hold
11,395
0.36% 59
2023
Q2
$2.53M Sell
11,395
-20
-0.2% -$4.64K 0.29% 69
2023
Q1
$2.76M Hold
11,415
0.33% 69
2022
Q4
$3M Hold
11,415
0.37% 63
2022
Q3
$2.57M Sell
11,415
-115
-1% -$27.9K 0.35% 64
2022
Q2
$2.81M Sell
11,530
-400
-3% -$98K 0.36% 63
2022
Q1
$2.88M Hold
11,930
0.32% 65
2021
Q4
$2.68M Buy
11,930
+631
+6% +$133K 0.27% 70
2021
Q3
$2.4M Hold
11,299
0.27% 70
2021
Q2
$2.75M Sell
11,299
-18
-0.2% -$4.43K 0.31% 67
2021
Q1
$2.82M Buy
11,317
+1
+0% +$239 0.34% 66
2020
Q4
$2.6M Sell
11,316
-171
-1% -$39.4K 0.32% 64
2020
Q3
$2.92M Hold
11,487
0.39% 60
2020
Q2
$2.71M Hold
11,487
0.39% 59
2020
Q1
$2.33M Sell
11,487
-76
-0.7% -$16.6K 0.39% 60
2019
Q4
$2.79M Hold
11,563
0.38% 63
2019
Q3
$2.24M Hold
11,563
0.33% 66
2019
Q2
$2.13M Hold
11,563
0.32% 67
2019
Q1
$2.2M Buy
11,563
+34
+0.3% +$6.49K 0.34% 69
2018
Q4
$2.24M Sell
11,529
-435
-4% -$84.9K 0.4% 66
2018
Q3
$2.48M Hold
11,964
0.39% 68
2018
Q2
$2.21M Hold
11,964
0.38% 70
2018
Q1
$2.04M Sell
11,964
-99
-0.8% -$18.2K 0.37% 71
2017
Q4
$2.1M Sell
12,063
-237
-2% -$41.9K 0.36% 72
2017
Q3
$2.29M Sell
12,300
-200
-2% -$35.4K 0.41% 65
2017
Q2
$2.15M Hold
12,500
0.41% 67
2017
Q1
$2.05M Hold
12,500
0.39% 68
2016
Q4
$1.83M Hold
12,500
0.36% 73
2016
Q3
$2.08M Hold
12,500
0.41% 66
2016
Q2
$1.9M Buy
12,500
+35
+0.3% +$5.44K 0.37% 67
2016
Q1
$1.87M Hold
12,465
0.36% 71
2015
Q4
$2.02M Hold
12,465
0.4% 65
2015
Q3
$1.72M Sell
12,465
-300
-2% -$47.3K 0.35% 73
2015
Q2
$1.97M Sell
12,765
-100
-0.8% -$16K 0.38% 68
2015
Q1
$2.06M Hold
12,865
0.4% 66
2014
Q4
$2.05M Hold
12,865
0.4% 64
2014
Q3
$1.8M Buy
12,865
+25
+0.2% +$3.26K 0.38% 63
2014
Q2
$1.51M Hold
12,840
0.32% 71
2014
Q1
$1.58M Buy
12,840
+200
+2% +$24.3K 0.34% 65
2013
Q4
$1.44M Buy
12,640
+100
+0.8% +$11.4K 0.32% 69
2013
Q3
$1.4M Buy
12,540
+207
+2% +$22.4K 0.34% 67
2013
Q2
$1.22M Buy
+12,333
New +$1.28M 0.31% 68

Other funds holding AMGN

Wendell David Associates's AMGN Position: Q2 2026 in Review

Wendell David Associates reduced its Amgen (AMGN) stake by 0.46% in Q2 2026, selling an estimated $17.1K and leaving 10,743 shares worth $3.89M. The position accounts for 0.41% of the portfolio, ranked #55.

Wendell David Associates first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Wendell David Associates held 10,743 shares of Amgen worth $3.89M as of Q2 2026.
  • Wendell David Associates sold 50 Amgen shares in Q2 2026, an estimated $17.1K.
  • Amgen made up 0.41% of Wendell David Associates's portfolio in Q2 2026, its #55 holding.
  • Wendell David Associates first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.